NCCIH’s Role in the NIH HEAL Initiative
NCCIH is playing a major role in the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, a trans-agency effort focused on improving prevention and treatment strategies for opioid misuse and addiction, and enhancing pain management. Launched in April 2018 with funding from Congress, the initiative brings new hope for individuals, families, and communities affected by the national opioid public health crisis.
NCCIH is leading or co-leading the following NIH HEAL Initiative programs.
- Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM)
- Behavioral Research to Improve Medication Assisted Treatment (BRIM)
- The NIH Back Pain Research Consortium (NIH BACPAC)
- New Funding Opportunity on Biomarkers for Myofascial Pain
- Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium
Find information on all NIH HEAL Initiative New Funding Opportunities and Funded Projects.
All NIH funding opportunities related to pain are available on the NIH Pain Consortium website.
New NIH HEAL Initiative on Developing Imaging of Biomarkers of Myofascial Tissues
Dr. Helene M. Langevin, director of the National Center for Complementary and Integrative Health, and Dr. Bruce Tromberg, director of the National Institute for Biomedical Imaging and Bioengineering, discuss a new funding opportunity from the NIH HEAL® (Helping to End Addiction Long-term) Initiative that will focus on the development of innovative quantitative imaging and relevant biomarkers of myofascial tissues for pain management.
Non-drug Treatments for Pain and Opioid Use Disorder
NCCIH leads the way for two NIH HEAL Initiative studies: PRISM and BRIM
Dr. Langevin Introduces NCCIH’s Involvement in the NIH HEAL Initiative
Dr. Helene M. Langevin, director of the National Center for Complementary and Integrative Health, explains the Center’s role as the Federal Government’s lead agency for complementary and integrative health.